Earlier, Be Swasth Healthcare Limited was known as Be Swasth Healthcare Limited. Be Swasth Healthcare Limited was initially registered as a Non-Banking Financial Institution (NBFC) with the Reserve Bank of India. However, on August 2nd, 2018, the company voluntarily surrendered its NBFC registration to the RBI and ceased to be an NBFC from that date onwards. In the year 2020, Be Swasth Healthcare Limited amended its object clause to include Tele Health services as part of its business diversification.
| Be Swasth Healthcare Outstanding Shares: | 11,19,000 |
| Face Value of Be Swasth Healthcare Unquoted Share: | Rs. 10 Per Equity Share |
| ISIN of Be Swasth Healthcare Unquoted Share: | INE288U01011 |
| Lot Size of Be Swasth Healthcare Unquoted Share: | 100 Shares |
| Be Swasth Healthcare Share Price: | Best in Industry |
| PAN Number of Be Swasth Healthcare : | AAACU0056D |
|
Be Swasth Healthcare Limited CIN Number |
L93000DL1985PLC021397 |
|
|
Be Swasth Healthcare Limited Registration Date |
02 July 1985 |
|
|
Category / Sub-Category of Be Swasth Healthcare |
Company limited by Shares/ Non-govt company |
|
|
Be Swasth Healthcare Registered Office Address |
A-6/343B, 1st Floor, Janta Flats, Paschim Vihar, New Delhi New Delhi DL 110063 IN |
|
|
Be Swasth Healthcare Registrar & Transfer Agent Address & Contact Details |
Beetal House 99 Madangir Behind LSC Nr Dada Harsukhdar Delhi - 110062 |
Virender Kumar Jain, Director
Nirmal Jain, Director
Ganesh Ray, Independent Director
Meenu Paliwal, Independent Director
Neha Jain, Company Secretary
Anshul Akash, Whole-time Director
Vinit, Whole-time Director
Sushma Jain, Addtnl Independent Director
|
Name and Description of main products/services |
NIC Code of the product/service* |
% to the total turnover of the Company |
|
Human Health Activities |
851 |
100% |
The Company doesn’t have any subsidiary, joint venture or associate company.
S. No. | Shareholder’s Name | No. of Shares | % of total Shares of the company |
1 | Promoter | 0 | NIL |
2 | Public Shareholding | 11,19,000 | 100% |
| Total | 11,19,000 | 100% |
FAQs on Be Swasth Healthcare Ltd
Q: What is the face value of Be Swasth Healthcare Ltd shares?
Answer: The face value of Be Swasth Healthcare Ltd is ₹10 per equity share.
Q: What is the minimum lot size for buying Be Swasth Healthcare shares through WWIPL?
Answer: The minimum lot size for Be Swasth Healthcare shares is 100 equity shares.
Q: How can I buy Be Swasth Healthcare unlisted shares through WWIPL?
Answer: Investors can complete the KYC process, confirm the transaction details with WWIPL, transfer funds, and receive shares directly in their Demat account.
Q: Why should I buy Be Swasth Healthcare shares through WWIPL?
Answer: WWIPL offers transparent pricing, secure transactions, seamless Demat transfers, and dedicated support throughout the investment process.
Q: Is investing in Be Swasth Healthcare Ltd a good idea?
Answer: Investors often evaluate Be Swasth Healthcare based on its telehealth business, financial performance, business transformation, valuation, and long-term growth potential in the healthcare sector.
Q: Why do investors buy Be Swasth Healthcare shares before a potential IPO?
Answer: Investors seek early exposure to a healthcare company with the expectation of long-term value creation and potential liquidity through a future listing.
Q: What business does Be Swasth Healthcare Ltd operate in?
Answer: Be Swasth Healthcare operates in the Healthcare sector. The company was previously registered as an NBFC but voluntarily surrendered its RBI registration in 2018. In 2020, it diversified its business by amending its object clause to include telehealth services.
Q: Who founded Be Swasth Healthcare Ltd?
Answer: Be Swasth Healthcare Ltd was incorporated on 2 July 1985. The company has evolved from a former NBFC into a healthcare-focused business with telehealth services.
Q: What makes Be Swasth Healthcare different from other unlisted healthcare companies?
Answer: Be Swasth Healthcare stands out because of its transition from a non-banking financial company to a healthcare business focused on telehealth services, reflecting a strategic shift toward digital healthcare.
Q: What are the key growth drivers for Be Swasth Healthcare Ltd?
Answer: Growth is supported by increasing adoption of telehealth services, digital healthcare expansion, operational improvements, technological advancements, and rising demand for accessible healthcare solutions.
Q: What factors affect the valuation of Be Swasth Healthcare shares?
Answer: Revenue growth, profitability, telehealth adoption, financial performance, business execution, market demand for unlisted shares, and future listing prospects are key valuation drivers.
Q: Are Be Swasth Healthcare shares available in Demat form?
Answer: Yes. Shares purchased through WWIPL are transferred directly to the investor's Demat account.
Q: Can I sell my Be Swasth Healthcare shares through WWIPL?
Answer: Yes. WWIPL facilitates both buying and selling of unlisted shares, subject to market demand and share availability.
Q: What documents are required to buy Be Swasth Healthcare shares through WWIPL?
Answer: Investors generally need PAN, Aadhaar, Client Master Report (CMR), and bank account details to complete the transaction.
Q: What are the risks of investing in Be Swasth Healthcare shares?
Answer: Investors should consider execution risks related to its business transformation, competition in digital healthcare, regulatory changes, profitability fluctuations, and liquidity constraints associated with unlisted shares.
Q: How does WWIPL help investors track Be Swasth Healthcare investments?
Answer: WWIPL provides company updates, transaction assistance, market information, and investment insights to help investors stay informed.
Q: How long does it take for Be Swasth Healthcare shares purchased through WWIPL to be credited to a Demat account?
Answer: Shares are generally transferred to the investor's Demat account after successful completion and verification of the transaction.
Q: What should investors evaluate before investing in Be Swasth Healthcare Ltd?
Answer: Investors should assess the company's financial performance, telehealth business model, profitability, valuation, balance sheet strength, and long-term growth prospects.
Q: Can Be Swasth Healthcare benefit from India's growing digital healthcare industry?
Answer: Yes. Rising adoption of telemedicine, increasing healthcare digitization, greater internet penetration, and growing demand for remote healthcare services may create long-term growth opportunities for the company.
